TL;DR
Get everyday helpers delivered free with Prime
- Fast, free delivery on millions of items
- Prime Video, Amazon Music and more included
- Member-only deals all year
A 14-year analysis of 5,423 adults in England found that cardiovascular disease was associated with faster decline in global cognition, memory, orientation and verbal fluency. Researchers also found that the association varied across groups defined by long-term depressive symptom patterns, but the study cannot show that depression or heart disease caused cognitive decline.
A 14-year study of 5,423 adults aged 50 and older in England found that cardiovascular disease was associated with faster decline in cognitive test scores, while the pattern of that association varied across groups with different long-term depressive symptom trajectories. Published in Scientific Reports, the analysis identifies an association, not proof that heart disease or depression causes changes in brain aging.
According to the study in Scientific Reports, researchers analyzed data from waves 2 through 9 of the English Longitudinal Study of Ageing, collected between 2004–2005 and 2018–2019. The final sample had a mean age of 65.2; 1,080 participants, or 19.9%, reported cardiovascular disease at the start of the analysis. The study defined cardiovascular disease using participants’ reports of a physician diagnosis, including angina, heart attack, heart failure, stroke or other heart problems.
In the researchers’ adjusted analyses, participants with cardiovascular disease had an additional average annual decline of 0.045 standard deviations in global cognition compared with those without it. The paper also reported faster decline associated with cardiovascular disease in semantic fluency, memory and orientation. These are average differences in test-score trajectories, not a measure of an individual’s likelihood of developing dementia.
The study authors used repeated assessments of depressive symptoms to sort participants into low-stable, moderate-stable and high-stable trajectories. These groups accounted for 76.8%, 18.1% and 5.1% of participants, respectively. Cardiovascular disease was more prevalent in the groups with higher symptom levels: 17.5% in the low-stable group, 26.2% in the moderate-stable group and 33.7% in the high-stable group. The researchers also reported that depressive symptom burden was associated with poorer cognitive performance and faster decline.
How Heart Health Relates to Cognitive Change
The findings add evidence that heart health, mood symptoms and cognitive change may be related in later adulthood. The study authors reported associations across several cognitive domains, which may interest researchers studying factors linked to changes in memory and thinking, as well as clinicians and public health planners considering the health needs of older adults.
The study’s value is in examining depressive symptoms over time, rather than relying only on one assessment. Its results suggest that symptom patterns may matter when researchers study cardiovascular disease and cognition together. The authors do not show that treating depression or cardiovascular disease will prevent cognitive decline, and the paper does not establish an individual prognosis.
Popular right now
Apple AirPods Max 2 Wireless Over-Ear Headphones – Midnight
Apple AirPods Pro 3 Wireless Earbuds with Active Noise Cancellation
Breville BES870XL Barista Express Espresso Machine, Brushed Stainless Steel
As an affiliate, we earn on qualifying purchases.
How Researchers Tracked Symptoms and Cognition
As described in the paper, the study drew on the English Longitudinal Study of Ageing, a nationally representative research project following adults aged 50 and older in England. Of 9,432 people considered initially, 5,423 were included after exclusions for missing cardiovascular information, too few cognitive or depression assessments, or incomplete baseline details.
The researchers measured depressive symptoms with eight questions from the CES-D scale, covering symptoms rather than providing a clinical diagnosis of depression. Cognitive tests assessed immediate and delayed recall of 10 words, identification of the current date, and the number of animals a participant could name in one minute. The study authors combined standardized domain scores into a global cognition measure and adjusted analyses for factors including age-related demographics, socioeconomic position, smoking, physical activity, hypertension and diabetes.
The authors noted that cardiovascular disease and depressive symptoms have each been associated in prior research with poorer cognitive outcomes. Their additional research question was whether long-term patterns of depressive symptoms changed the observed relationship between cardiovascular disease and cognitive decline.
Causation and Timing Remain Unresolved
The study authors describe the analysis as observational, so it cannot establish that cardiovascular disease or depressive symptoms caused the changes in test scores. They also report an important timing limitation: depressive symptoms and cognitive changes were assessed over overlapping periods. As a result, the analysis could not determine whether persistent symptoms came before cognitive decline.
The symptom groups reflect patterns measured by a screening scale, not formal depression diagnoses. Cardiovascular disease was based on self-reported physician diagnoses, and the final sample was smaller than the initial study pool because some participants lacked required data. The supplied study report says the association varied by depressive symptom trajectory but does not provide the specific between-group estimates needed to quantify how much it differed for each group. The results also do not establish whether the same patterns apply to people outside the study population.
Further Studies Must Clarify the Link
The study report does not describe a planned follow-up study or a scheduled next milestone. Further research would need to test whether depressive symptom patterns precede changes in cognition, and examine the size and consistency of the association across groups. Studies with measures that better establish timing, along with replication in other populations, could help clarify how the observed relationships fit together.
For now, the study offers longitudinal evidence of associations, not evidence that a particular treatment will change cognitive outcomes. Readers should not interpret the findings as a diagnosis or as a basis for changing care; personal medical decisions should be discussed with a qualified health professional.
Key Questions
What did the study find?
In the study published in Scientific Reports, cardiovascular disease was associated with faster average decline in global cognition and in measures of memory, orientation and semantic fluency among 5,423 adults aged 50 and older in England. The researchers also reported that the association varied across groups with different long-term depressive symptom trajectories.
Does the study show that heart disease causes cognitive decline?
No. The authors conducted an observational study, which can identify associations but cannot establish that cardiovascular disease caused the cognitive changes.
Were participants diagnosed with depression?
Not on the basis of the symptom measure described in the study. Researchers used repeated responses to eight CES-D questions to classify symptom trajectories. Those patterns are not the same as clinical depression diagnoses.
Why is the role of depression still uncertain?
As the study authors note, depressive symptoms and cognitive changes were measured during overlapping follow-up periods. The analysis therefore could not establish whether persistent symptoms preceded cognitive decline, and the reported results do not quantify the differences between each trajectory group.
Can the findings predict an individual’s dementia risk?
No. The study reports average associations in a group and does not provide an individual risk prediction or show that participants’ test-score changes represent dementia diagnoses.
Source: news-medical.net
